Loading

International Journal of Clinical Anesthesiology

Adverse Events in Procedural Sedation for the Dental Chair: Analysis of 800 Patients Managed with the Association Midazolam or Fentanyl

Research Article | Open Access

  • 1. Consultant Anesthesiologist, Italy
+ Show More - Show Less
Corresponding Authors
Claudio Melloni, Consultant Anesthesiologist, Private practice, Office: via Fossolo 28, 40138, Italy, Tel: 0039 051 39004; 0039 335 309504; Fax:0039 051 443106
Abstract

Purpose: This study evaluated the adverse events [AEs] rates of sedation with midazolam and fentanyl in ambulatory patients undergoing oral surgery.

Methods: 844 consecutive patients aged 8-95 years, ASA class 1-4, undergoing oral surgery [multiple surgical extractions, wisdom teeths extractions, difficult conservative care, sinus lift, bone grafts] were sedated with small dosages of midazolam and fentanyl under full monitoring (ECG, NIBP [non invasive blood pressure], SaO2, et CO2] with the aim to maintain conscious sedation (CS) [Ramsay scale score 3-4]. AEs included episodes [number and/or duration] of hypertension, hypotension, tachycardia, bradycardia, hypercapnia, desaturation, sleepiness. AEs were correlated to demographic and study variables with a multivariate analysis .

Results: Patients were premedicated with various drugs before the induction of CS. Surgery lasted a mean of 118 +/- 55 min:mean midazolam and fentanyl dosage were 0.048 +/- 0.029 mg/kg and 0.79 +/- 0.60 microgr/kg respectively. Per cent of cases [%] occurrence of AEs was : desaturation [SaO2 95 mmHg or BP >25% basal ] 17.9, hypotension[ systolic or diastolic 25% of basal], hypercapnia 38.4 [etCO2 >40 mmHg], sleepiness 21 [Ramsay 5][duration 4.3 +/- 11 min]. All surgeries were completed and patients sent home with a responsible adult within 2 hours.

Hypertension hypotension, tachycardia occurrences were associated with ASA, age, dosages of midazolam .Bradycardia was associated with age. Desaturation cases,duration and episodes were linked to the drugs used [midazolam and fentanyl]. Sleepiness was accompanied by desaturation and hypotension and little influenced by drugs dosages.

Discussion: Aes were frequent but of relatively minor intensity and all responded to the approriate therapy. Titration of sedatives and analgesics was kept to a minimun compatible with the condition of the patient and the extent of surgery.

Safety in the dentist office can be maintained with the careful monitoring of the vital signs under this drug regimen [midazolam and fentanyl] assuring the maintenance of conscious sedation.Any derangement from the normal physiology must be timely and properly treated.

Citation

Melloni C (2017) Adverse Events in Procedural Sedation for the Dental Chair: Analysis of 800 Patients Managed with the Association Midazolam/Fentanyl. Int J Clin Anesthesiol 5(1): 1064.

INTRODUCTION

Following the ban on the administration of general anesthesia in the dentist’s office prompted by the UK government with the report “A conscious decision [1] prompted by a series of papers on morbidity and mortality on the dental chair [2,3] there has been a growing interest in the field of sedation and sedation plus analgesia for the dental chair, with the aim to render tolerable to an increasing number of patients the longer and more invasive procedures.

Quite few references in the dental literature specifically address the issue of the safety of sedation in the context of the dentist’s office apart papers dealing with general recommendations [4] or special subgroups [5].

Data from the American Society of Anesthesiologists, Closed Claims database [6] suggest that anesthesia at remote locations poses a significant risk for the patient, particularly related to over sedation and inadequate oxygenation/ventilation during monitored anesthesia care [MAC].

While the published series of the closed claims analysis deals mainly with the most severe adverse events, like death or brain damage, it would be interesting to know which are the dangers, if any of the practice of analgesia-sedation for the dental chair.

Sedation is a continuum process [7] starting with full wakefullness with maintenance of the protective reflexes ,passing along minimal, then moderate, then deep sedation and arriving at general anesthesia, with a continuous increasing depression of all physiological systems when the patient vital signs need to be artificially supported;therefore a major concern for physicians doing sedation is to maintain a balance between comfort for the patient [and surgeon alike] and safety,avoiding adverse events [AE’s] which are still occurring during deep sedation and general anesthesia [8].

Adverse events [AEs] that may occur during procedural sedation include a host of problems and particularly respiratory depression and apnoea, hypoxemia, haemodynamic disturbances, nausea and vomiting that may lead to aspiration of gastric content into the lungs.

Quoting the Task Force Committee on AEs [9]. “Actual injury is usually averted by either spontaneous resolution of the event or by intervention of the sedation care provider. These events are often referred to as ‘near misses’ or ‘close calls’, but in fact, rarely pose any serious danger [permanent neurological injury or mortality] when managed by a skilled practitioner in an appropriate setting.” Because AEs have been classified differently across the years and different institutions a recently appointed international task Force [ibidem [9] defined AE as a ‘Unexpected and undesirable response[s] to medication [s] and medical intervention used to facilitate procedural sedation and analgesia that threaten or cause patient injury or discomfort’. Ae’s were graded as major, intermediate and minor according to their grade of aggressiveness in endangering the patient and following the extent of the intervention required with the intention to treat the AE.

With the aim to contribute to the literature on safety for procedural sedation in the dentist office we present a case series of patients candidate to dental surgery in various dentist offices undergoing conscious sedation with midazolam and fentanyl.Ae’s were classified according to the task force quoted above [ibidem] [9]. In particular attention was paid to haemodynamic derangements, [tachycardia, bradycardia, hypotension, hypertension], desaturation, as evidence of hypoxemia,hyercapnia as sign of respiratory depression.

Aim of the study has been to search the correlation, if any, between patient demographics, intraprocedural data and incidence of adverse effects.

MATERIALS AND METHODS

The study includes 844 patients operated upon by the same anesthesiologist [CM] between January 1 2010 and December 31 2016 in various dental offices ,mainly for multiple implants, extraction of wisdom teeth and/or conservative care.with or without bone graft.

Anesthetic aim was to maintain a state of conscious sedation ,evaluated every 5-10 min according to the Ramsay scale [10] and kept between the score 2-3[patiemt calm ,oriented,responding to commands, cooperative];any overshoot[Ramsay 4 or 5 ]was defined as “sleep” and considered an AE. Data of the patients were collected on a special sheet; vital signs were measured every 5/10 min and included HR derived from ECG or pulsoximeter], NIBP, SaO2, etCO2 [whenever possible ]. EtCo2 was measured through silicone nasal prongs [Salter labs R divided cannulas] with a sidestream capnograph [NPB 70-75 ]. Patients were seated on a dental chair,maintained their own clothes and were covered with special surgical drapes on the chest and face .

The day before the procedure patients were reminded to refrain form solids for at least 6 hours; clear liquids were allowed until 2 hrs before the arrival in the office. On arrival in the dental suite patients filled in a detailed health questionnaire [often sent by email days in advance] and signed a consent form for conscious sedation; if time allowed, they were premedicated orally (Table 1). Patients were instructed to take at home all their usual medications including antihypertensive ,antiarrhythmic ,cardiotonic pills ;only metformin was avoided before surgery. Patients on vit K inhibitors were operated with INR <2.5 checked the day before or the morning of surgery. ASA or ticlodipine was not stopped when prescribed by the cardiologist for preexisting pathologies [TIA, AFs, DVT s etc.]. Patients were stratified according their physical status with the ASA classification [11]. Once seated on the dental chair, patients were attached to the monitors [Datex Cardiocap II,Datex Ohmeda S/5 light, Meditech ] ecg continuous, [3 or 5 leads], NIBP every 5 min for at least the first 30 min, then every 5/10 min], SaO2 continuously from finger tip or lobe of the right ear, etCO2 continuously, if available; a suitable vein was cannulated [20-22g] [Jelco R or TerumoR] in the hand or forearm and normal saline infused at a rate of approximately 1,5 ml/kg/h . Sedation [conscious] was cautiously induced with a small bolus of midazolam [1-3 mg] and fentanyl [25-50 microgr]; local analgesia was administered by the attending dentist as appropriate with articaine 4% or mepivacaine 2% with epinephrine when the patient appeared calm and cooperative [Ramsay score 2-3] .

Hypertension, hypotension,tachycardia ,bradycardia were defined as exceeding 25% of the basal values measured at the beginning of the procedure, following the premedication, if administered and before venous cannulation.

Hypercapnia was defined as etCO2 >40 mmHg; its duration and/or number of episodes were noted.

Desaturation was defined as SaO2<90; its duration and /or number of episodes noted .

Diastolic pressure >95 mmHG >5 min was [also defined as hypertension] treated with clonidine 0.5-0.75 microgr/kg, i.v repeated after 30 min if ineffective.

HR <50 /min[also defined as bradycardia] was treated with atropine 0.5 mg.

All other complaints or symptoms [pain,nausea,etc] were treated at the discretion of the anesthesiologist:haloperidol 0.5-1 mg injected for nausea,ephedrine [5-10 mg] for hypotension,small boluses fentanyl [10-25 microgr] or meperidine [10-20 mg] or remifentanyl [10-20 nanograms] or ketamine [10-20 mg] given for breaktrough pain .In cases of severe gagging problems patients received additional small propofol boluses [10-20 mg], especially during moulding.

Patients were kept in the semireclined position [25-30°] or supine during the entire operation.

Supplemental oxygen at a rate of 1-2 lt min was given through the nasal prongs as long as needed to avoid hypoxemia .

Ketorolac 30 mg was given for articular/muscular /bone complaints either during or at the end of the operation ;at the completion of the procedure ibuprofen 400-600 mg p.os and/ or dexamethasone [4 mg] i.v. were given at the discretion of the attending dentist.

In case of prolonged sleepiness [i.e. Ramsay 4] naloxone and/ or flumazenil were given at the discretion of the anesthesiologist. All patients were discharged home within 2 hours from the end of the intervention accompanied by a responsible adult. Adverse events were defined as fluctuations of blood pressure , heart rate, etCO2 as defined ;other symptoms or discomforts were also noted.

Table 1: Data of the patients and study.

  frequency or interval % mean Std dev +/-
Sex:
f
m
522
322
61,8
38,1
   
ASA class 1:422
2:308
3:106
4:8
50
36,5
12,6
0,9
   
Age,years 8-96   59,2 14,6
Weight,kg 27-145   70,7 15,4
Height,cm 125-193   169 55
Time to procedure[min] 0-150   24 16,3
Procedure duration[min] 5-350   118 55
Midaz mg/kg total 0-0,18   0.048 0,029
Fentanyl microgr/kg total 0-3,64   0,79 0,60
SaO2<90% 149 pts 17,7    
Duration of desaturation min 0-85   2.50 8,8
Episodes of desaturation number Min 0,max 15   0,34 1
Hypertension [yes/no] 151 17,9    
Hypotension[yes/no] 31 3,7    
Bradycardia[yes/no] 34 4,0    
Tachycardia[yes/no] 5 0,6    
Hypercapnia[yes/no] 324 38,4    
Hypercapnia duration min 0[357 pts]-335[1 pat]   29 33,2
Sleep[yes/no] 179pts,,0-95 min      
Sleep duration [min] 5-95 min   4.3 11
         
Premedication: drug name        
None 121 14,3    
Midazolam 152 18    
Midazolam+ haloperidol 45 5,3    
Midazolam +ibuprofen 86 10,2    
Diazepam 298 35,3    
Ibuprofen alone 3 0,4    
Diazepam +haloperidol 2 0,2    
Triazolam+ ibuprofen 18 0,1    
Triazolam alone 44 14,3    
Diazepam+ibuprofen 1 18    
Droperidol or haloperidol alone 1 0,1    
triazolam+codeine+paracetamol 27 3,2    
diazepam+codeine+paracetamol 19 2,3    
Midazolam+codeine+paracetamol 3 0,3    
Diazepam+haloperidol 16 1,9    
diazepam+ibuprofen 4 0,5    
etCO2 was not measured in 164 cases.

 

STATISTICS

Data are presented as mean +/- d.s.;univariate or multivariate analysis of variance was applied to search for correlation between adverse events and the data collected using version 24 of SPSS. Values of P>0.05 were accepted as significant. Anova was also applied in a comparison betweeen blood pressures [systolic and diastolic] of patients receiving a premedication or none (Table 2).

Table (3) presents the [minor] adverse effects that occurred; number and % quoted as well as duration of desaturation and hypercapnia.

Table 2: Results of Anova for type of preanesthesia and basal blood pressures, before sedation Systolic Blood pressure.

Type of Premedication Mean S. D
1=midazolam 133 20
2=midazolam+neuroleptic 129 18
3=midazolam+FANS 131 17
4=diazepam 135 21
7=triazolam+FAns 127 20
8=triazolam 142 23
12=triazolam+paracetamol+codeine 142 23
14=diazepam+paracetamol+codeine 133 15
42=diazepam+neuroleptic 134 20
0=none 147 22
*groups<10 cases were omitted, F=6.408, p<0.001 Diastolic Blood pressure
  Mean SD
1=midazolam 82 13
2=midazolam+neuroleptic 78 16
3=midazolam+FANS 78 14
4=diazepam 80 13
7=triazolam+FAns 75 15
8=triazolam 85 14
12=triazolam+paracetamol+codeine 80 12
14=diazepam+paracetamol+codeine 80 14
42=diazepam+neuroleptic 80 10
0=none 87 14
*Groups < 10 cases were omitted F=4.64,p<0.001

Table 3: Frequency and duration of the adverse effects.

Adverse effect number % Mean S.D. 95% +/-
hypertension No:693 82.11      
  Yes:151 18.88      
hypertension NO:813 96.33      
  Yes:31 3.67      
bradycardia No:810 95.97      
  Yes:34 4.03      
tachycardia No:839 99.41      
  Yes:5 0.59      
desaturation No:695 82.35      
  Yes::149 17.65      
hypercapnia No:362 42.89      
  Yes:324 38.33      
  n/a:158 18.72      
sleep No:695 78.79      
  yes:179 21.21      
desaturation duration[min]     2.5 8.34 0.56
desaturation episodes [num]     0.33-1   0.07
sleep duration[min]     4.2 10.9

0.73

hypercapnia duration[min]     38.25 44.7 4.92
      median:20    

 

RESULTS

Age and asa class were higly correlated.

The incidence of hypertension was associated with ASA class [signif 0.000], dosage of fentanyl [0.000], dosage of midazolam [0.001].

The incidence of hypotension was associated with ASA class [signif 0.012], age [0.000], with the dosage of fentanyl [but… P 0.052].

The incidence of bradycardia was associated with age [0.028]

The incidence of tachycardia was associated with age [0.000],ASA class [0.000], dosage of midazolam [0.013].

The incidence od desaturation was associated with the dosage of midazolam [but 0.049…].

The duration of desaturation was associated with the dosage of midazolam [0.001] and fentanyl [0.003].

The number of episodes of desaturation was associated with dosage of midazolam [0.005] and fentanyl [0.038].

The incidence f hypercapnia was associated with the dosage of fentanyl .

The duration of hypercapnia was associated with age [0.005] and dosage of fentanyl [=.000]. The % increase in the etCO2 was associated with dosage of fentanyl [0.030]

Desaturation and hypotension were significantly linked [0.000]

Incidence of sleep was associated with hypotension [but 0.05…], desaturation[0.000].

Incidence of sleep duration was associated with dosage of fentanyl [0.024], desaturation [0.000], hypotension [0.001

Blood pressures of patients who received a premedication differed from those not receiving any form of premed.[P<0.001].

DISCUSSION

All Aes resolved rapidly with the appropriate measures,i.e. tapping or calling loudly the patients in cases of sleep, administering clonidine for hypertension or atropine for bradycardia etc.;in no case Aes proceeded from minor to intermediate;in no case there was the need for airway interventions except the administratioo of supplementary oxygen in cases of desaturation.Often borderline saturation [90%] was allowed to continue as long as etCO2 was satisfactory or slightly elevated [41-42 mmHg] and the patient remained conscious and cooperative .

Elevated blood pressure and etCO2 represented the most frequent AEs .

It is no wonder that hypoventilation was linked to the combined administration of the hypnotic[midazolam] and the analgesic opioid fentanyl; this is the price to pay in order to obtain a calm and cooperative patient allowing the surgeon to proceed with the intended operation without haste and stress .A moderate hypoventilation revealed by the increase in etCO2 and its per cent increase above the basal values is the norm following these potent drugs: the potentiating effect of their combination [12] has been widely recognized.

Only the judicious titration of the respective dosages might forestall the complications arising in case of severe depression of ventilation with the need of rescue manoeuvres. As shown in the results dosage of both drugs was kept at a minimum compatible with the success of sedation and surgery, very rarely exceeding a total of 5 mg of midazolam and 100 micrograms of fentanyl for surgeries lasting more than 2 hours. Many studies show a clear link between use of sedation and risk of hypoxemia [13-14]. Few dental references were found in which the oxygen saturation levels recorded during sedations were used as a determinant of safety [15]. These authors noted that the variables that were significantly associated with low saturations were age, gender, and weight. either the dose of midazolam nor the additional use of propofol was a significant risk factor. These findings are quite different from ours where the addition of the opiate fentanyl is responsible for desaturation. Their impressive statistics of 3500 cases done by a single operator/sedationist supported by trained nurse demonstrated safe levels of oxygenation with sedative hypnotics like midazolam and/ or propofol;the problem changes with the addition of fentanyl,where our opinion is in favour of the presence of the anesthesiologist. Perrott and colleagues [16] reported on 34,191 patients who underwent oral surgical procedures using various anesthetic techniques. In this study, 5299 patients were under conscious sedation. The complication rate was 1.3%, although no details of the nature of the complications were given, other than that they were ‘minor and self-limiting.’ The authors concluded that conscious sedation was safe and associated with a high level of patient satisfaction. Milgrom and colleagues [17] reported on 207 sedations that tested the hypothesis that combined drug therapy [midazolam and fentanyl, or a double-blind placebo] results in significantly poorer safety but no difference

in efficacy, compared with the single drug approach.; in fact the addition of the narcotic resulted in apnea in 63% of cases versus 3% in the midazolam-only group. Interestingly, patients in the combination drug group were 4 times more likely to report an ‘‘excellent sedation’’ versus ‘‘good, fair, or poor’’ in the single drug group.

Jastak and Peskin [18] reported on 13 deaths under dental sedation between 1974 and1989 in the USA. They examined the physical status of the patient, anesthetic technique used probable cause of the morbid event; avoidability of occurrence, and contributing factors. They found that most patients were classified as ASA II or III with significant pre-existing conditions [obesity, cardiac disease, obstructive pulmonary disease]. Hypoxemia was the most common cause of untoward events. Most events were determined to be avoidable. The authors felt that sedation risks increased significantly in patients with a score of greater than ASA I and with extremes of age.

Midazolam, fentanyl, [and propofol] all depress respiratory drive and increase risk of apnea and hypoxemia; therefore a reasonable measure of safety is to examine the oxygen saturation levels recorded during sedations because it is hypoxemia that poses the greatest risk of morbidity or mortality. However our cases are the proof that with great care even some high risk patients could be sedated with no untoward sequelae.

Hypertension must be regarded probably more as a side effects of dental surgery than an AE;in fact ,beside the expected coincidence of high blood pressure and advanced age,the administration of the local anesthetic containing epinephrine could contribute to the rise of the blood pressure, albeit it has been shown its relative safety even in hypertensive patients [19- 21].

Our analysis showed occasional peaks of blood pressure from the baseline following the top ups of the LA during the course of the procedure,but the nature of our data collection and flowchart precluded further analysis.In every case clonidine was administered when diastolic pressure exceeded 95 mmHG, 5 mmHg above the consensus limit of high blood pressure definition [22-23] : all cases were treated succesfully.Very often hypertension present at the induction of CS abated as soon as the patient reached a Ramsay score of 3, so that its aetiology could be attributed to the preexisting fear or anxiety rather than hypertension per se. Continuing in the same line of reasoning the association noted between hypertension and the additional doses of midazolam and fentanyl points out the need for more sedation and analgesia, so that it could be considered a case of a cause and effect consequence . Beside it is our opinion that pain occurring during the operation should be treated with top ups of local anesthetics ,being aware not to cross the boundaries of systemic local anesthetics toxicity , since more fentanyl means to increase the danger of hypoventilation and desaturation .The choice of clonidine offers a specific advantage:beside being a good hypotensive agent,it is acting synergistically with sedatives and fentanyl [24].

Bradycardia is a more serious concern in our practice,where the danger of vagal stimulation is always operating and constitutes a serious problem in young vagotonic athletes:however all patients responded promptly to the injection of atropine 0.5 mg : only 10 cases required supplementary doses. Its association with advancing age is surprising: the reason could be the fact that many hypertensive patients assumed their betablocker / calcium channel blocker shortly before surgery,hence arriving in the office at the peak of effect of the drugs. Again, these relationships were not investigated further because the nature of our data sheet.

Tachycardia increases the oxygen consumption and may provoke coronary constriction, angina and even heart failure.It was generally noted at the beginning of the procedure and hence considered more a sign of patient stress; it generally resolved after a few minutes in the vast majority of cases, without beta or calcium blockers.Its association with midazolam may represent the dominant sympathetic effect exhibited by the drug during CS as shown by Heuss et al.[25].

Desaturation, its duration and number of episodes were associated with the administration of midazolam and fentanyl; this is a well known consequence of their pharmacological actions and no other measures were taken except for the administration of supplementary oxigen: high risk patients [frail and elderly,overweight, ASA 3 and 4 patients] received oxygen at the induction prophylactically.

End tidal CO2 monitoring has been included between the standard of care by the ASA since 2010 for general anesthesia, moderate sedation, and deep sedation [26].

Several studies demonstrate that respiratory depression is detected via end-tidal capnography30-60 seconds prior to detection via oxygen saturation [SaO2 ][ 27].

Under clinical steady state conditions there is a good correlation between microstream capnometry and arterial carbon dioxide partial pressure; the relationship holds true even with patients intubated and mechanically ventilated [28].Values and tracings may differ between different types of cannula and various fresh oxygen flows [29] and cannot accurately follow arterial CO2 in sleep hypoventilation [30] and even more so in COPD patients or whenever the tracing is erratic by mouth breathing,or other surgical disturbances .Notwithstanding these limitations ,it is however a vey useful adjunct to the monitoring of the vital signs of our patients.Moreover as arterial CO2 tension rise ,as reflected in the etCO2 , a compensatory increase in minute ventilation occurs, accompanied by an increase in tidal volume [31] so that, in a certain sense,the increase in etCO2 could be considered “useful” in our patients,provided that oxygenation and haemodynamics remain between physiological limits.

Desaturation,hypotension and sleep where significantly linked : the aetiology of these disturbances was attributed to the drugs used for sedation/analgesia.From this point of view it is of utmost importance to maintain the verbal contact with the patient,encouraging occasional deep breaths in order to correct hypoxemia and hypoventilation and at the same time improving the quality of the capnogram.

This study has several limitations: data are retrospective ,collected upon rigid templates ;therefore ,for instance , hypertension caused by the epinephrine contained in the LA cannot be differentiated by that arising from breaktrough pain or insufficient analgesia,either local or systemic. In some cases eleveations of blood pressure occurred during the last periods of surgery and we attributed its etiology to the fact that local anesthesia was wearing off.In these cases more systemic sedatives or analgesics could have postponed the discharge of the patient from the dental chair so that we chose not to administer more drug ;as a matter of fact we believe that the best option for breaktrough pain occurring near the end of surgery should again to inject more local..In these cases ketorolac was used, providing some comfort.

Premedication choice and dose was not standardized since very often it depended from the local drug availability and/ or dentist preference. We consider the administration of some tranquilizer before the induction of CS a very valuable way to attenuate fear and anxiety. This result has been shown in the difference between blood pressures measured at the induction of CS, significantly different betwen premedicated and non premedicated patients (Table 2). There is always a certain interval of time between the anesthesiologist arrival in the dentist office and the induction of CS [on the average around 20 min]; this time is spent by the anesthesiologist setting up all the necessary medications and monitors and checking all the equipment and could be used to sedate the patient and obtain valuable information about its drug tolerance.

We chose a very low level of SaO2 [90%] as a threshold limit for desaturation and classifying it as an AE; in many studies in the dental literature [and not limited to dentistry] the safety limit has been posted at 94% [32].

The steepness of the oxyhemoglobin curve indicates a dangerously low level of PaO2 at 90% saturation.However we were administering oxygen immediately as needed, monitoring etCO2, maintaining contact with the patient and were capable of any rescue manoeuver in case of need.We were dealing mainly with adult patients,where airway rescue manoeuvers are much more easily applied than in kids,where the desaturation threshold should be higher, at least 94%, since youngsters desaturate easily even following sedatives alone [33].

Finally, midazolam and fentanyl dosages were administered as needed at the discretion of the anesthesiologist following dosages based more on personal experience than as recommended according to age, weight, comorbidites [34].

In conclusion, careful titration of midazolam and fentanyl accompanied by non invasive full monitoring of patients vital signs by a dedicated anesthesiologist represent a safe practice for conscious sedation in the dentist office .

REFERENCES

1. A conscious decision. A review of the use of general anaesthesia and conscious sedation in primary dental care Report by a Group chaired by the Chief Medical Officer and Chief Dental Officer U.K. Department of Health. 2000.

2. Mortality on the dental chair [UK] 1984-1993. Seel D. Dental General Anaesthesia. Report of a Clinical Standards Advisory Group Committee on General Anaesthesia for Dentistry. London: Department of Health, 1995.

3. Poswillo D. General anaesthesia, sedation and resuscitation in dentistry. Report of an Expert Working Party for the Standing Dental Advisory Committee. London: Department of Health, 1990.

4. Guideline for Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures: Update 2016. Pediatr Dent. 2016; 38: 216-245.

5. Kang J,Vann WF Jr, Lee JY, Anderson JA. The safety of sedation for overweight/obese children in the dental setting. Pediatr Dent. 2016; 38: 216-245.

6. Metzner J, Posner KL, Domino KB. The risk and safety of anesthesia at remote locations: the US closed claims analysis.Curr Opin Anaesthesiol. 2009; 22: 502-508.

7. Continuum of Depth of Sedation: Definition of General Anesthesia and Levels of Sedation/Analgesia. Committee of Origin: Quality Management and Departmental Administration. 2014.

8. Bennett JD, Kramer KJ, Bosack RC. How safe is deep sedation or general anesthesia while providing dental care?. J Am Dent Assoc. 2015; 146: 705-708.

9. Mason K. P, Green SM, Piacevoli Q. Adverse event reporting tool to standardize the reporting and tracking of adverse events during procedural sedation: aconsensus document from the World SIVA International Sedation Task Force. Br J Anaesth. 2012; 108: 13-20.

10. Ramsay MA, Savege TM, Simpson BRJ, Goodwin R. Controlled sedation with alpaxalone-alphadolone. Br Med J. 1974; 2: 656-659.

11. Asa physical status classification system Last approved by the ASA House of Delegates on October 15, 2014.

12. Ben-Shlomo I, Abd-el-Khalim H, Ezry J, Zohar S, Tverskoy M. Midazolam acts synergistically with fentanyl for induction of anaesthesia. Br J Anaesth. 1990; 64: 45-47.

13. Walton G, Boyle C, Thompson P. Changes in oxygen saturation using two different sedation techniques. Br J Oral Maxillofac Surg. 1991; 29: 87-89.

14. Hovagin A, Vitkun S, Manecke G, Reiner R. Arterial oxygen desaturation in adult dental patients receiving conscious sedation. J Oral Maxillofac Surg. 1989; 47: 936-939.

15. Viljoen A, Byth K, Coombs M, Mahoney G, Stewart D, Royal Australian College of Dental Surgeons; Australian and New Zealand College of Anaesthetists. Analysis of oxygen saturations recorded during dental intravenous sedations: a retrospective quality assurance of 3500 cases. Anesth Prog. 2011; 58: 113-120.

16. Perrott DH, Yuen JP, Dodson TB. Office based ambulatory anaesthesia: outcomes of clinical practice of oral and maxillofacial surgeons. J Oral Maxillofac Surg. 2003; 61:981-982.

17. Milgrom P, Beirne OR, Fiset L, Weinstein P, Tay KM, Martin M. The safety and efficacy of outpatient midazolam intravenous sedation for oral surgery with and without fentanyl. Anesth Prog. 1993; 40: 57-62.

18. Jastak JT, Peskin RM. Major morbidity or mortality from office anesthetic procedure: a closed-claim analysis of 13 cases. Anesth Prog. 1991; 38: 39-44.

19. Abu-Mostafa N, Aldawssary A, Assari A, Alnujaidy S, Almutlaq A. A prospective randomized clinical trial compared the effect of various types of local anesthetics cartridges on hypertensive patients during dental extraction. Clin Exp Dent. 2015; 7: 84-88.

20. Serrera Figallo MA, Velázquez Cayón RT, Torres Lagares D, Corcuera Flores JR, Machuca Portillo G .Use of anesthetics associated to vasoconstrictors for dentistry in patients with cardiopathies. Review of the literature published in the last decade. J Clin Exp Dent. 2012; 4: 107-111.

21. Uzeda MJ, Moura B, Louro RS, da Silva LE, Calasans-Maia MD. A randomized controlled clinical trial to evaluate blood pressure changes in patients undergoing extraction under local anesthesia with vasopressor use. J Craniofac Surg. 2014; 25: 1108-1110.

22. McGraw-Hill. Concise Dictionary of Modern Medicine. 2002 by the McGraw-Hill Companies, Inc.

23. Medical Dictionary for the Health Professions and Nursing. Farlex 2012.

24. Horvath G, Szikszay M, Benedek G. Potentiated hypnotic action with a combination of fentanyl, a calcium channel blocker and an alpha 2-agonist in rats. Acta Anaesthesiol Scand. 1992; 36:170-174.

25. Heuss L, Schnieper P, Drewe J, Pflimlin E, Beglinger C. Safety of propofol for conscious sedation during endoscopic procedures in high-risk patients: a prospective, controlled study. Am J Gastroenterol. 2003; 98: 1751-1757.

26. The American Society of Anesthesiologists [ASA] standards for basic anesthetic monitoring Committee of Origin: Standards and Practice Parameters. 2015.

27. Anderson CT, Breen PH. Carbon dioxide kinetics and capnography during critical care. Crit Care. 2000; 4: 207-215.

28. Casati A, Gallioli G, Scandroglio M, Passaretta R, Borghi B, Torri G. Accuracy of end-tidal carbon dioxide monitoring using the NBP 75 microstream capnometer. A study in intubated ventilated and spontaneously breathing nonintubated patients. Eur J Anaesthesiol. 2000; 17: 622-626.

29. Ebert TJ, Novalija J, Uhrich TD, Barney JA. The effectiveness of oxygen delivery and reliability of carbon dioxide waveforms: a crossover comparison of 4 nasal cannulae. Anesth Analg. 2015; 120: 342-348.

30. Won YH, Choi WA, Lee JW, Bach JR, Park J, Kang SW. Sleep Transcutaneous vs. End-Tidal CO2 Monitoring for Patients with Neuromuscular Disease. Am J Phys Med Rehabil. 2016; 95: 91-95.

31. Rigg JRA, Rondi P. Changes in rib cage and diaphragm contribution to ventilation after morphine. Anesthesiology. 1981; 55: 507-514.

32. Nagels AJ, Bridgman JB, Bell SE, Chrisp DJ. Propofol-remifentanil TCI sedation for oral surgery. N Z Dent J. 2014; 110: 85-89.

33. Johnson E, Briskie D, Majewski R, Edwards S, Reynolds P. The physiologic and behavioral effects of oral and intranasal midazolam in pediatric dental patients. Pediatr Dent. 2010; 32: 229-238.

34. Midazolam (Rx). Drugs & Diseases.

Received : 25 Jan 2017
Accepted : 14 Apr 2017
Published : 17 Apr 2017
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X